These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24228403)

  • 21. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 2. Diseases originated from stem cell abnormalities; 4) The intestinal epithelial stem cells and cancer stem cells].
    Tsuchiya K
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2273-8. PubMed ID: 24228411
    [No Abstract]   [Full Text] [Related]  

  • 22. Regenerative medicine for urological tissues: Updated review 2018.
    Kanematsu A
    Int J Urol; 2018 Sep; 25(9):788-791. PubMed ID: 30066462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 2. Diseases originated from stem cell abnormalities; introduction].
    Akashi K; Ueda T
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2254. PubMed ID: 24228407
    [No Abstract]   [Full Text] [Related]  

  • 24. [111th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium; 2. Perspective of treatment in the vascular lesion of various organs; 4) Pathophysiology of cerebral infarction and its new treatment].
    Tanahashi N
    Nihon Naika Gakkai Zasshi; 2014 Sep; 103(9):2149-57. PubMed ID: 27522767
    [No Abstract]   [Full Text] [Related]  

  • 25. [Stem cells: scientific progress and commercial tactics].
    Nau JY
    Rev Med Suisse; 2013 Oct; 9(400):1794-5. PubMed ID: 24187755
    [No Abstract]   [Full Text] [Related]  

  • 26. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 2. Diseases originated from stem cell abnormalities; 5) Stem cell disorders and epigenetics].
    Shimono Y
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2279-83. PubMed ID: 24228412
    [No Abstract]   [Full Text] [Related]  

  • 27. iPS cells--alternative pluripotent cells to embryo stem cells.
    Pei X
    Sci China Life Sci; 2010 Jan; 53(1):154-156. PubMed ID: 20596969
    [No Abstract]   [Full Text] [Related]  

  • 28. Current Public Support for Human-Animal Chimera Research in Japan Is Limited, Despite High Levels of Scientific Approval.
    Inoue Y; Shineha R; Yashiro Y
    Cell Stem Cell; 2016 Aug; 19(2):152-153. PubMed ID: 27494672
    [No Abstract]   [Full Text] [Related]  

  • 29. [Novel approaches for therapeutic kidney regeneration].
    Yokoo T
    Nihon Rinsho; 2007 Aug; 65(8):1529-37. PubMed ID: 17695295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human induced pluripotent stem cells: the past, present, and future.
    Hussein SM; Nagy K; Nagy A
    Clin Pharmacol Ther; 2011 May; 89(5):741-5. PubMed ID: 21430659
    [No Abstract]   [Full Text] [Related]  

  • 31. Nonhuman primate models in translational regenerative medicine.
    Daadi MM; Barberi T; Shi Q; Lanford RE
    Stem Cells Dev; 2014 Dec; 23 Suppl 1(Suppl 1):83-7. PubMed ID: 25457970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Generation of three-dimensional pancreatic tissue from human induced pluripotent stem cells].
    Sasaki B; Kawaguchi Y
    Nihon Rinsho; 2015 Dec; 73(12):2129-33. PubMed ID: 26666164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current status and perspective of regenerative medicine for diabetic nephropathy].
    Matsui S; Osafune K
    Nihon Rinsho; 2016 Apr; 74 Suppl 2():207-11. PubMed ID: 27266089
    [No Abstract]   [Full Text] [Related]  

  • 34. Stem cells have the potential to rejuvenate regenerative medicine research.
    Eve DJ; Fillmore R; Borlongan CV; Sanberg PR
    Med Sci Monit; 2010 Oct; 16(10):RA197-217. PubMed ID: 20885363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 2. Diseases originated from stem cell abnormalities; 1) Abnormalities in hematopoietic stem cells: congenital immunodeficiencies].
    Hara T
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2255-61. PubMed ID: 24228408
    [No Abstract]   [Full Text] [Related]  

  • 36. Japanese Laws and the Current Status of Regenerative Medicine in the Tohoku Region.
    Kamano Y; Terajima N; Chiba Y; Suresh VV; Saito M
    J Contemp Dent Pract; 2023 Feb; 24(2):120-128. PubMed ID: 37272144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New era of regenerative medicine for cardiovascular diseases.
    Tse HF
    Thromb Haemost; 2010 Jul; 104(1):4-5. PubMed ID: 20539908
    [No Abstract]   [Full Text] [Related]  

  • 38. Highlight: 'regenerative hepatology'.
    Häussinger D; Sies H
    Biol Chem; 2009 Oct; 390(10):949-50. PubMed ID: 19764897
    [No Abstract]   [Full Text] [Related]  

  • 39. How far are induced pluripotent stem cells from the clinic?
    Li M; Chen M; Han W; Fu X
    Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induced pluripotent stem cells: an emerging theranostics platform.
    Nelson TJ; Terzic A
    Clin Pharmacol Ther; 2011 May; 89(5):648-50. PubMed ID: 21512525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.